Latest Surgical oncology Stories

Authors recommend evaluation program of institutions In other studies, outcomes of specific surgeries has been shown to improve when performed at high-volume centralized centers. Researchers from the Netherlands Cancer Institute wanted to understand if patients undergoing lung cancer resections would benefit from having their procedures performed in a high-volume specialized center. The study, published in the July 2012 issue of the International Association for the Study of Lung Cancer's...

SYOSSET, N.Y., June 1, 2012 /PRNewswire/ -- Dr. Myron Arlen, of Great Neck, New York, has been included in the Strathmore's Who's Who Worldwide Edition for his outstanding contributions and achievements in the field of Biotechnology. About MYRON ARLENDr. Myron Arlen has over 50 years experience in the biotechnology arena. He founded Neogenix Oncology in 2003, a clinical stage biotechnology company focused on developing therapeutic and diagnostic products for the early detection and...

A novel pancreatic cancer vaccine shows promise in improving survival when added to standard treatment, according to new research out of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine. The Phase 2 data was presented today (embargoed 11:00 am ET) at the Annual Meeting of the Society for Surgery of the Alimentary Tract, part of Digestive Disease Week in San Diego. In the plenary session titled "Addition of...

CLEVELAND, May 22, 2012 /PRNewswire/ -- A novel pancreatic cancer vaccine shows promise in improving survival and represents a potential breakthrough in the treatment of this deadly disease. Jeffrey Hardacre, MD, of University Hospitals Case Medical Center's Seidman Cancer Center and Case Western Reserve University School of Medicine presented results of a Phase 2 clinical trial in patients with pancreatic cancer testing the Algenpantucel-L vaccine today at the Annual Meeting of the...

Novel grafts reduces need for permanent tracheotomy, maintain voice and swallowing function Massachusetts General Hospital (MGH) surgeons have developed a new technique for reconstructing the larynx after surgery for advanced cancer. In the May Annals of Otology, Rhinology and Laryngology, they describe how this approach – which uses cryopreserved aortas from deceased donors to replace removed larynx tissue – allowed patients to avoid a permanent tracheotomy and maintain voice and...

A study of 7,424 privately insured colon cancer patients found that managed care presence in the market and hospital competition increased the likelihood laparoscopic surgery to treat colon cancer lowered costs, a national team of researchers led by a professor at the George Washington University School of Public Health and Health Services reported in the journal Cancer, May 8, 2012. Colon cancer is the second leading cause of cancer death in the U.S., and surgical resection is the...

Surgery to remove only the tumor preferable to removing entire kidney Kidney cancer patients who had only their tumor removed had better survival than patients who had their entire kidney removed, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. After an average of five years, 25 percent of patients who had a so-called partial nephrectomy, in which only the tumor and a small margin of healthy tissue is removed, had died, while 42...

Treatment with aromatase inhibitors enables some women to have lumpectomy Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla. "We found that half of the postmenopausal women in the study...

LOS ANGELES, March 23, 2012 /PRNewswire/ -- The Society of Surgical Oncology (SSO) and its James Ewing Foundation recognized the efforts of Stand Up to Cancer's co-founder Lisa C. Paulsen toward eradicating cancer by presenting her the SSO's 2012 James Ewing Layman's Award at the Society's Annual Cancer Symposium in Orlando, Florida on March 23rd. The James Ewing Layman's Award is presented annually and is intended to thank and honor non-physicians for their work in support of...

VIENNA, March 22, 2012 /PRNewswire/ -- Dune Medical Devices, the manufacturer of the MarginProbe(®) System, held a satellite symposium featuring discussions with experts in the field of breast cancer regarding the treatment of women with early stage breast cancer and the importance of margin assessment in breast conserving surgery. The panel conducted a thorough review of clinical experience with the MarginProbe System, designed to improve a surgeon's ability to identify the...